Traumatic Brain Injury Therapeutics - Pipeline Assessment and Market Forecasts to 2019GlobalDataJune 18, 2012 98 Pages - SKU: GBDT3940497 |
Additional Information
Need for Further Research into Brain Injuries Creates Opportunities for Pharma.Opportunities exist for pharmaceutical companies to increase their offerings in the traumatic brain injury (TBI) market, as current therapeutic options for TBI patients
More CNS/Neurology reports by GlobalData
Anorexia Nervosa Global Clinical Trials Review, H1, 2013 by GlobalData
Anorexia Nervosa Global Clinical Trials Review, H1, 2013SummaryGlobalData's clinical trial report, “Anorexia Nervosa Global Clinical Trials Review, H1, 2013 provides data on the Anorexia Nervosa ...
Dyslexia Global Clinical Trials Review, H1, 2013 by GlobalData
Dyslexia Global Clinical Trials Review, H1, 2013SummaryGlobalData's clinical trial report, “Dyslexia Global Clinical Trials Review, H1, 2013 provides data on the Dyslexia clinical trial scenario. ...
Tcelna (Multiple Sclerosis) - Forecast and Market Analysis to 2022 by GlobalData
Tcelna (Multiple Sclerosis) - Forecast and Market Analysis to 2022SummaryGlobalData has released its new PharmaPoint Drug Evaluation report, “Tcelna (Multiple Sclerosis) - Forecast and Market ...
NU-100 (Multiple Sclerosis) - Forecast and Market Analysis to 2022 by GlobalData
See all reports like this >>NU-100 (Multiple Sclerosis) - Forecast and Market Analysis to 2022SummaryGlobalData has released its new PharmaPoint Drug Evaluation report, “NU-100 (Multiple Sclerosis) - Forecast and Market ...
Research assistance
We can help you find what you need. Call us or write us: Need help in your search?
US: 800.298.5699
Int'l: +1.240.747.3093
Related Markets
CNS/Neurology Reports
